We recently compiled a list of the 8 Best Small Cap Pharma Stocks to Buy Right Now. Emergent BioSolutions Inc. (NYSE:EBS) is one of the best pharmaceutical stocks to invest in. TheFly reported on ...

Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food and Drug Authority (SFDA) has approved the registration of ACAM2000® [Smallpox and Mpox (Vaccinia) ...

Emergent BioSolutions (Emergent), a vaccine manufacturer located in East Baltimore, has come under fire for intentionally misleading the FDA about the mishandling of COVID-19 vaccines. Rep. Carolyn B.

Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash. Its flagship product, Narcan, will ...

Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals. What Happened: On Thursday prior ...

Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: June 8: presentation and webcast, ...

View Emergent BioSolutions Inc. EBS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Lindahl provided initial 2026 guidance: "total revenues expected in the range of $720 million to $760 million. MCM revenue is expected to be flat to slightly down with continued strength in ...

Emergent BioSolutions just got a nod from regulators for over-the-counter use of a product to fight opioid overdose. Invitae is making progress on a plan to reach positive cash flow. Sometimes, a ...

An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and investors reacted quite positively to the move. On the news, they piled into ...